Richard Rychlik serves as Executive at Armata Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Richard Rychlik has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 14, 2024 involved receiving (via award) 10,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 14, 2024 | ARMP | $0 | Award | 10,000 | $N/A | Discretionary |
Richard Rychlik currently holds 10,000 shares of Armata Pharmaceuticals, Inc. (ARMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Rychlik has been a net neutral trader of ARMP stock. They have purchased $0 and sold $0 worth of shares.
Richard Rychlik's most recent insider trade was on Mar 14, 2024, when they sold 10,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted